Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 188 citing articles:

SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas
Janis A. Müller, Rüdiger Groß, Carina Conzelmann, et al.
Nature Metabolism (2021) Vol. 3, Iss. 2, pp. 149-165
Open Access | Times Cited: 507
SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment
Chien-Ting Wu, Peter V. Lidsky, Yinghong Xiao, et al.
Cell Metabolism (2021) Vol. 33, Iss. 8, pp. 1565-1576.e5
Open Access | Times Cited: 300
COVID-19, Hyperglycemia, and New-Onset Diabetes
Kamlesh Khunti, Stefano Del Prato, Chantal Mathieu, et al.
Diabetes Care (2021) Vol. 44, Iss. 12, pp. 2645-2655
Open Access | Times Cited: 278
Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning
Daniel J. Drucker
Cell Metabolism (2021) Vol. 33, Iss. 3, pp. 479-498
Open Access | Times Cited: 239
COVID-19 and metabolic disease: mechanisms and clinical management
Charlotte Steenblock, Peter E. H. Schwarz, Barbara Ludwig, et al.
The Lancet Diabetes & Endocrinology (2021) Vol. 9, Iss. 11, pp. 786-798
Open Access | Times Cited: 206
New onset diabetes, type 1 diabetes and COVID-19
Sirisha Kusuma Boddu, Geeta Aurangabadkar, Mohammad Shafi Kuchay
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 14, Iss. 6, pp. 2211-2217
Open Access | Times Cited: 174
COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course
Cyril P. Landstra, Eelco J.P. de Koning
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 174
SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in β Cells
Katie C. Coate, Jeeyeon Cha, Shristi Shrestha, et al.
Cell Metabolism (2020) Vol. 32, Iss. 6, pp. 1028-1040.e4
Open Access | Times Cited: 167
Viral infiltration of pancreatic islets in patients with COVID-19
Charlotte Steenblock, Stefanie Richter, Ilona Berger, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 166
Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19
Irina Kusmartseva, Wenting Wu, Farooq Syed, et al.
Cell Metabolism (2020) Vol. 32, Iss. 6, pp. 1041-1051.e6
Open Access | Times Cited: 160
Can COVID-19 cause diabetes?
Domenico Accili
Nature Metabolism (2021) Vol. 3, Iss. 2, pp. 123-125
Open Access | Times Cited: 127
Diabetes, obesity, and insulin resistance in COVID-19: molecular interrelationship and therapeutic implications
Andrey Santos, Daniéla Oliveira Magro, Rosana Evangelista Poderoso, et al.
Diabetology & Metabolic Syndrome (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 119
Virus Infections and Host Metabolism—Can We Manage the Interactions?
Deepak Sumbria, Engin Berber, Manikannan Mathayan, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 113
Incidence of Type 1 Diabetes in Children and Adolescents During the COVID-19 Pandemic in Germany: Results From the DPV Registry
Clemens Kamrath, Joachim Rosenbauer, Alexander J. Eckert, et al.
Diabetes Care (2022) Vol. 45, Iss. 8, pp. 1762-1771
Open Access | Times Cited: 108
Impact of COVID-19 on the Endocrine System: A Mini-review
Sophie Clarke, Ali Abbara, Waljit S. Dhillo
Endocrinology (2021) Vol. 163, Iss. 1
Open Access | Times Cited: 100
Post-acute sequelae of COVID-19: A metabolic perspective
Philipp E. Scherer, John P. Kirwan, Clifford J. Rosen
eLife (2022) Vol. 11
Open Access | Times Cited: 75
An Immediate and Long-Term Complication of COVID-19 May Be Type 2 Diabetes Mellitus: The Central Role of β-Cell Dysfunction, Apoptosis and Exploration of Possible Mechanisms
Melvin R. Hayden
Cells (2020) Vol. 9, Iss. 11, pp. 2475-2475
Open Access | Times Cited: 87
Organ-specific genome diversity of replication-competent SARS-CoV-2
Jolien Van Cleemput, Willem van Snippenberg, Laurens Lambrechts, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 64
Diabetes and COVID-19; A Bidirectional Interplay
Paraskevi Kazakou, Vaia Lambadiari, Ignatios Ikonomidis, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 64
Diabetes mellitus and COVID-19: Understanding the association in light of current evidence
Saikat Sen, Raja Chakraborty, Pratap Kalita, et al.
World Journal of Clinical Cases (2021) Vol. 9, Iss. 28, pp. 8327-8339
Open Access | Times Cited: 63
The SARS-CoV-2 receptor ACE2 is expressed in mouse pericytes but not endothelial cells: Implications for COVID-19 vascular research
Lars Muhl, Liqun He, Ying Sun, et al.
Stem Cell Reports (2022) Vol. 17, Iss. 5, pp. 1089-1104
Open Access | Times Cited: 62
SARS-CoV-2 infection of the pancreas promotes thrombofibrosis and is associated with new-onset diabetes
Mirza Muhammad Fahd Qadir, Manika Bhondeley, Wandy L. Beatty, et al.
JCI Insight (2021) Vol. 6, Iss. 16
Open Access | Times Cited: 56
Consequences of COVID-19 for the Pancreas
Urszula Abramczyk, Maciej Nowaczyński, Adam Słomczyński, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 864-864
Open Access | Times Cited: 52
Limited extent and consequences of pancreatic SARS-CoV-2 infection
Verena van der Heide, Sonia Jangra, Phillip Cohen, et al.
Cell Reports (2022) Vol. 38, Iss. 11, pp. 110508-110508
Open Access | Times Cited: 48
Page 1 - Next Page

Scroll to top